SEC Form 4 · accession 0001140361-16-072507
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Jul 14, 2016
Accepted (ET)
Jul 14, 2016 · 9:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Jul 14, 2016 | S | 2,753 | $65.0177 | D | 40,669 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $65.00 to $65.10. The price reported above reflects the weighted average sale price.